Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

8 resultsUpdated October 23, 2026
1

Novel Strategies Enhancing Bioavailability and Therapeutical Potential of Silibinin for Treatment of Liver Disorders

Drug Design Development and Therapy Volume 18 (2024)

Michal Šelc; Radka Macova; Andrea Bábelová

2

Synergy of Phospholipid—Drug Formulations Significantly Deactivates Profibrogenic Human Hepatic Stellate Cells

Pharmaceutics 11(12) (2019)

Gina Valentino; Cristina Zivko; Florian Weber; Lorine Brülisauer; Paola Luciani

3

Silybin Modulates Collagen Turnover in an In Vitro Model of NASH

Molecules 24(7) (2019)

Beatrice Anfuso; Pablo José Giraudi; Claudio Tiribelli; Natalia Rosso

4

Silybin Showed Higher Cytotoxic, Antiproliferative, and Anti-Inflammatory Activities in the CaCo Cancer Cell Line while Retaining Viability and Proliferation in Normal Intestinal IPEC-1 Cells

Life 13(2) (2023)

Dominika Faixová; Marek Ratvaj; Ivana Cingeľová Maruščáková; Gabriela Hrčková; Viera Karaffová; Z. Faixová; Dagmar Mudroňová

5

The pattern of IL-24/mda-7 and its cognate receptors expression following activation of human hepatic stellate cells

Biomedical Reports 7(2) (2017)

Iman Jamhiri; Seyed Younes Hosseini; Davood Mehrabani; Zahra Khodabandeh; Ramin Yaghobi; Razieh Dowran; Saber Zahri

6

Enhancing the apoptotic effect of IL-24/mda-7 on the human hepatic stellate cell through RGD peptide modification

Immunological Investigations 47(4) (2018)

Iman Jamhiri; Saber Zahri; Davood Mehrabani; Zahra Khodabandeh; Mehdi Dianatpour; Ramin Yaghobi; Seyed Younes Hosseini

7

The evaluation of fibrotic effects of the hepatitis B virus pre-core in hepatic stellate cells

Biomedical Reports 6(6) (2017)

Seyed Younes Hosseini; Kazem Baesi; Negar Azarpira; Ameneh Pakneiat; Seyedeh Akram Hosseini